WE MAKE DRUG ALLERGY DIAGNOSTICS ACCURATE, ACCESIBLE AND FAST.
Engineering Biosensors Powered by Photonics and Nanomaterials
Empowering Healthcare Through Innovation
Our technology combines proprietary integrated photonics with exclusive surface chemistry and nanomaterials to create label-free biosensors. These sensors enable fast and reliable biomarker detection, streamline workflows, and enhance diagnostic accuracy across a wide range of clinical and research applications.
Transforming Drug Allergy Diagnostics
We deliver AllerWAVE®, an innovative in vitro diagnostic technology for fast, accurate, and accessible detection of antibiotic allergies and acute drug reactions. Our compact tabletop analyzer and disposable cartridges are designed for efficiency in hospitals and labs, with no need for specialized personnel.
Fighting Misdiagnoses and Antimicrobial Resistance
Over 90% of reported penicillin allergies are incorrect, leading to suboptimal treatments and contributing to the projected 10 million AMR-related deaths by 2050. AllerWAVE® ensures accurate diagnosis, enabling proper antibiotic use and helping preserve life-saving therapies.
WHO WE ARE
The Company
Bioherent is a deep-tech SME founded in 2021 as a spin-off from the University of Málaga. Backed by three leading research groups in integrated photonics, organic chemistry, and medicine, we develop next-generation biosensing solutions to transform diagnostics. Our multidisciplinary team brings together expertise in photonics, surface chemistry, nanomaterials, microfluidics, immunology, quality, and regulatory affairs. With a strong commitment to scientific rigor, innovation, and gender diversity, we bridge the gap between cutting-edge research and real-world healthcare.
Our mission is to make diagnostics faster, more accurate, and accessible—empowering decentralized disease detection and monitoring with compact, reliable tools.
Technology
Shaping the Future of Diagnostics
The Power of Silicon Photonics
Every time you browse the internet, your data travels as light through fiber optic cables and is converted into electricity by silicon photonics. This technology has revolutionized e.g. high-speed internet by enabling rapid data transfer. Now, Bioherent is adapting silicon photonics to power the next generation of IVD tools.
It provides:
- Label-free detection,
- Fully-automated analysis
- Minuaturized platforms
- Scalable manufacturing
Advanced Chemistry and Nanotechnology
Accurate drug allergy detection requires biorecognition surfaces that mimic how allergens interact with the immune system at the molecular level. At Bioherent, we engineer silicon surfaces for exceptional sensitivity and specificity. Our optimized procedures set a new benchmark in diagnostic accuracy.
It provides:
- High sensitivity and specificity
- Superior reproducibility
- Enhanced signal amplification
- Selective detection in complex samples
Business
Our Solutions
Bioherent delivers next-generation solutions for drug allergy diagnostics, advanced biosensing with functionalized nanoparticles, and OEM photonic biosensor technology for seamless integration into third-party platforms
AllerWave ®
AllerWAVE® Next Generation Biosensing for Drug Allergy and Anaphylaxis Diagnosis
Bioherent is transforming drug allergy diagnostics with next-generation, label-free biosensing technology that delivers superior accuracy, accessibility, and speed. Our compact, fully automated tabletop instrument—paired with single-use AllerWAVE® cartridges—enables near-patient testing that is simple, cost-effective, and does not require specialized personnel or complex lab infrastructure.
We offer two complementary diagnostic solutions to support clinical decisions
- AllerWAVE® Antibiotic for detecting immediate allergic reactions to antibiotics
- AllerWAVE® Anaphylaxis for identifying acute, life-threatening allergic reactions
NanoKit ™
NanoKit™ – Custom Silica Nanoparticles for Advanced Biosensing and Research
At Bioherent, we offer high-performance silica nanoparticles tailored to your biomedical research needs. Available in 50 nm and 100 nm sizes, our particles come with a wide range of surface modifications—from versatile terminal groups like amine and carboxyl, to advanced multivalent systems including dendrimer coatings, silanized surfaces, and custom antibody functionalization.
Designed for demanding R&D applications, NanoKit™ supports target capture, signal amplification, surface engineering, and analysis of complex samples. They are compatible with multiple detection methods, including fluorescence, chemiluminescence, plasmonics, and electrochemical readouts.
Whether you need a standard formulation or a fully customized solution, our expert team will help you develop silica nanoparticles optimized for your specific application.
NanoKit™ is for research use only.
OEM Biosensor Solutions
Scalable Photonic Modules for Custom Applications
Partner with Bioherent and unlock the power of photonic integrated biosensors. Our proprietary, miniaturized photonic modules can be licensed and integrated into third-party platforms to enable label-free, real-time detection of biological targets with exceptional sensitivity and specificity. Whether you’re developing point-of-care diagnostics, environmental monitoring tools, or industrial biosensing systems, we offer scalable, high-performance solutions tailored to your needs. We provide technical support, customization, and co-development options to accelerate your path from concept to product.
Bring photonic biosensing into your application—without reinventing the core technology.
Partnership
Why choose Bioherent
At Bioherent, we combine cutting-edge technology with expert leadership to deliver decentralized, label-free diagnostic solutions. Backed by a strong clinical network and strategic partnerships, we address unmet medical needs in allergy and acute care—driving scalable impact and global growth.
Innovation for Decentralized Diagnostics
Label-free, fully automated solutions for disease diagnostics and monitoring, built on unique technology backed by strong IP.
Strong Team and Strategic Partnerships
Led by experts in photonics, surface chemistry, and medicine, with a reputable clinical panel ensuring trial execution and certification.
Market impact and future growth
Positioned to address critical diagnostic gaps in allergy and acute care, with a scalable model ready for international growth.
OUR VALUES
Driven by innovation and excellence
At Bioherent, we are committed to advancing accurate and accessible diagnostics for better patient care, fostering an inclusive culture that values individual responsibility, and building a sustainable, innovation-driven business that supports regional growth and European technological leadership
Our Customers
Our Employees
Our Shareholders
OUR BLOG
One Insight Ahead
Contact us
DATA CONTROLLER:
Bioherent, SL – CIF/NIF: B06987903, Address: Severo Ochoa, 34, 7211 – Research and experimental development in biotechnology. Telephone: +34 91 423 70 72, Email: info@bioherent.com
At Bioherent, we process the information you provide to provide the service you requested on the website and to process your billing or contract. The data provided on Bioherent.com will be retained for the duration of the business relationship or for the time necessary to comply with legal obligations and address any potential liabilities that may arise from the purpose for which the data was collected. The data will not be transferred to third parties except in cases where there is a legal obligation. You have the right to obtain information about whether Bioherent is processing your personal data. You can exercise your rights of access, rectification, erasure, data portability, and objection and restriction to processing by contacting us at contact@bioherent.com.
